₹ 256000 / 2000 Shares Shares
Minimum Investment
₹120-128 per equity share
07 Nov 2025
11 Nov 2025
1000
₹ 256000
₹120-128
14 Nov 2025
21,50,000 shares(aggregating up to ₹27.52 crore)
₹10 Per Equity Share
2000 Shares
2000 Shares
Established in 2010, Curis Lifesciences Limited is a pharmaceutical company specializing in the development, manufacturing, and distribution of a diverse range of products. The company manufactures pharmaceutical products both internationally and nationally on a loan license or on a contract basis, and for own brand marketing.The company serves over 100 corporate clients on loan licenses or contract manufacturing and 2 clients for its own brand marketing in Yemen and Kenya. Curis Lifesciences specializes in the development, manufacturing, and distribution of a broad array of pharmaceutical products that include: General pharmaceutical tablets and capsules Oral liquids External preparations Sterile ophthalmic ointments The firm has a state-of-the-art manufacturing facility in Sanand, Gujarat, operating under strict quality control measures to ensure the safety and efficacy of its products.The company offers different pharmaceutical formulations and products made on a contract basis.They provide tablets, capsules, external preparations, oral liquids, and sterile ophthalmic ointments. As of June 30, 2024, the company has 93 permanent employees.
2020
Dharmesh Dasharathbhai Patel
Curis Lifesciences Limited IPO
| Apply as | Price Range | Apply Upto |
|---|---|---|
| Individual (min) | ₹120-128 | ₹2,56,000 |
| Individual(max) | ₹120-128 | ₹2,56,000 |
| SHNI(min) | ₹120-128 | ₹3,84,000 |
| SHNI(max) | ₹120-128 | ₹8,96,000 |
| BHNI(min) | ₹120-128 | ₹10,24,000 |
Apply for all eligible candidates, Curis Lifesciences Limited IPO.
KSquare helps you select between Active and Auto choices based on your age, risk appetite, and retirement goals.
Yes, your mutual fund units continue to generate returns even while they are pledged for a loan.
Yes, KSquare builds dedicated SIP plans focused on medical security so unexpected health expenses don’t affect regular finances.
Unlike existing funds with track records, NFOs offer fresh investment opportunities, often at a face value of ₹10.
Yes, NPS offers disciplined savings, market-linked returns, and tax benefits, making it a strong choice for long-term retirement planning.
Yes, SIPs in ELSS funds qualify for tax deductions under Section 80C up to ₹1.5 lakh annually.
KSquare provides tax guidance specific to NRIs, helping you plan and stay compliant with Indian tax laws.
Yes, KSquare allows SIP setup, automating monthly investments to help build disciplined saving habits.